VivoSeq
26

Pipeline Programs

9

Active Trials

12

Companies Involved

Scoliosis is an emerging landscape with 26 programs across 12 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, Revance Therapeutics, Inc., Viatris Specialty LLC. 9 therapies are approved with 6 more in late-stage development.

Pipeline Metrics

Competitive Density

52/100

Pipeline Velocity

19/100

Mech. Concentration

13/100

Completion Rate

87/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

32

clinical trials

Completed13 · 41%
Unknown status8 · 25%
Recruiting5 · 16%
Not yet recruiting3 · 9%
Terminated2 · 6%
Enrolling by invitation1 · 3%

Trial Activity

32 trials

IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
Recruiting··Phase 2/3·NCT07217873·120 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)